Innovative treatment option for osteoarthritis, arthritis and cartilage defects
Autologous microtransplantation technology (AMT) is an innovative and non-surgical method for treating joint pain and regenerating cartilage tissue. It is used in particular for musculoskeletal disorders such as arthritis or osteoarthritis, whereby the therapy uses the body's natural ability to regenerate and completely dispenses with painkillers or other medication.
The AMT procedure (autologous microtransplantation) shows great potential in the treatment of pain and rehabilitation of joints with damaged cartilage tissue. Patients can benefit from significant improvements, particularly in diseases such as arthritis and osteoarthritis, but also after injuries or trauma that lead to stiffness and restricted movement.
As the regenerative capacity of conventional cartilage tissue is severely limited and there is often a lack of sufficient supply of nutrients and precursor cells, degenerative processes in affected joints - such as arthritis - often progress rapidly. The AMT procedure uses the microimplantation of tissue from the ear cartilage to stimulate the body's own regeneration processes. This can lead to pain relief as well as improved mobility and reduced stiffness in the joints.
The AMT procedure is suitable for almost all degenerative or injury-related cartilage damage in joints - especially in small joints such as the thumb saddle joint. This makes the method a promising option in modern regenerative medicine.
1. tissue removal: In the first step, autologous cartilage tissue, which is required for regeneration, is removed from the patient's ear cartilage, as the ear cartilage contains many precursor cells that can develop into new cartilage.
2. preparation and transplantation: The removed cartilage tissue is prepared and then implanted in the affected joints or in the area of cartilage damage. This process is minimally invasive, which means that it is carried out with as little intervention in the patient's body as possible.
3. regeneration and pain relief: After transplantation, the progenitor cells contained promote the regeneration of the cartilage. Many patients report significant pain relief and increased mobility after a short time.
The AMT procedure was developed by RegeneraActiva and is patented. Numerous clinical studies documenting positive results in pain relief and cartilage regeneration prove the effectiveness of the method.
Overall, autologous microtransplantation technology (AMT) is a promising and advanced treatment option for patients with joint pain and cartilage damage who are seeking relief and healing in a natural and gentle way. In our practice, too, we regularly see very good treatment results and a lasting improvement in quality of life.
This procedure treats the damaged cartilage with the AMT solution to promote regeneration and improve the function of the joint.
Einen Überblick über die Behandlungskosten erhalten Sie hier.
Please contact us by e-mail or telephone for a personal consultation.